A study shows that a cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men with prostate cancer that has spread.
It’s one of the biggest improvements in survival ever seen in an advanced cancer in adults.
Men who received the drug docetaxel (doe-suh-TAX-uhl) lived nearly 58 months versus 44 months for those not given the drug in the study, which was sponsored by the federal government.
The results were discussed Sunday at a meeting of more than 30,000 cancer specialists in Chicago.
Doctors say it shows the importance of testing older medicines now available in generic form. This one costs about $1,500 per treatment, far less than many newer drugs.
- Soon You Could Get Plastic Currency Notes: Find Out More
- Ranveer Singh and Vaani Kapoor Starrer Befikre Gets A Thumbs Up
- Supreme Court Seeks Centre’s Response Over Various Issues Regarding Demonetisation
- Defence Minister Manohar Parrikar Writes To West Bengal CM Mamata Banerjee
- Bigg Boss 10 December 8 Review: Swami Om Feels Cheated, lashes Out At Gaurav For Jail Punishment
- South Korean President Park Geun-Hye Impeached Over Corruption Scandal
- Former Air Chief SP Tyagi Arrested In VVIP Chopper Scam
- After Congress Vice President Rahul Gandhi, Liquor Baron Vijay Mallya’s Twitter Account Hacked
- Find Out What PM Narendra Modi Told Cabinet Over Demonetisation Decision
- Home Minister Rajnath Singh Assures Safety Of All Tourists Stranded On Havelock Island
- Government To Waive Service Tax On Debit, Credit Card Transactions Of Up To Rs 2,000
- President Pranab Mukherjee Criticises Parliament Disruptions Over Demonetisation
- Pakistan International Airlines Flight Carrying Over 40 Passenger On Board Crashes
- Shah Rukh Khan On Raees Clash With Kaabil: It’s Impossible To Have A Solo Release In India
- US-President Elect Donald Trump Named TIME’s Person Of The Year 2016